Qube Research & Technologies (QRT)
ORMP icon

Qube Research & Technologies (QRT)’s Oramed Pharmaceuticals ORMP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.9K Buy
+23,504
New +$79.7K ﹤0.01% 3105
2024
Q3 		– Sell
-107
Closed -$275 – 3893
2024
Q2 		$275 Sell
107
-88,089
-100% -$209K ﹤0.01% 3366
2024
Q1 		$258K Buy
88,196
+1,676
+2% +$4.69K ﹤0.01% 2900
2023
Q4 		$200K Buy
86,520
+76,630
+775% +$164K ﹤0.01% 2788
2023
Q3 		$25.8K Buy
+9,890
New +$31.1K ﹤0.01% 3070
2023
Q2 		– Sell
-31,309
Closed -$68.3K – 2829
2023
Q1 		$68.3K Sell
31,309
-11,522
-27% -$36.6K ﹤0.01% 2185
2022
Q4 		$515K Buy
42,831
+14,036
+49% +$109K ﹤0.01% 1459
2022
Q3 		$187K Sell
28,795
-24,333
-46% -$197K ﹤0.01% 1796
2022
Q2 		$243K Sell
53,128
-3,220
-6% -$17.2K ﹤0.01% 1655
2022
Q1 		$487K Sell
56,348
-8,451
-13% -$86.6K ﹤0.01% 1543
2021
Q4 		$925K Buy
+64,799
New +$1.35M 0.01% 1239
2021
Q3 		– Sell
-16,407
Closed -$220K – 2627
2021
Q2 		$220K Buy
+16,407
New +$188K ﹤0.01% 1747
2021
Q1 		– Sell
-54,291
Closed -$230K – 2280
2020
Q4 		$230K Sell
54,291
-21,104
-28% -$68.7K ﹤0.01% 1481
2020
Q3 		$197K Buy
75,395
+59,204
+366% +$206K ﹤0.01% 1401
2020
Q2 		$57K Buy
+16,191
New +$54.3K ﹤0.01% 1587

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ORMP Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Oramed Pharmaceuticals (ORMP) in Q1 2026: 23,504 shares worth $79.9K. The stake represents ﹤0.01% of the portfolio and ranks #3105 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in ORMP as recently as Q2 2024.

Qube Research & Technologies (QRT) first reported a position in ORMP in Q2 2020 and has held it in 15 quarters since. The position peaked at $925K in Q4 2021. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • Qube Research & Technologies (QRT) held 23,504 shares of Oramed Pharmaceuticals worth $79.9K as of Q1 2026.
  • Oramed Pharmaceuticals was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3105 holding.
  • Qube Research & Technologies (QRT) first reported a position in Oramed Pharmaceuticals in Q2 2020 and has held it in 15 quarters since.
  • Qube Research & Technologies (QRT)'s Oramed Pharmaceuticals position peaked at $925K in Q4 2021.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.